Article may be outdated

This article is 4 days old. Some details may have changed since publication.

Urology Times·4 min read·hard

Salvage Settings, Duration, and Next Steps in Very High-Risk Prostate Cancer

T
Tamim Niazi, MDCM
Salvage Settings, Duration, and Next Steps in Very High-Risk Prostate Cancer
✦AI Summary

Dr. Tamim Niazi discusses clinical strategies for high-risk prostate cancer, comparing different treatment cohorts and the efficacy of darolutamide. He emphasizes the importance of early staging and personalized treatment plans based on risk assessment tools.

Why it matters

Advancements in salvage therapy and risk stratification are essential for improving long-term survival rates and quality of life for prostate cancer patients.

✦Dive DeeperCreate a free account to unlock

Tamim Niazi, MDCM, begins by separating DASL-HiCaP's (NCT04136353) post-prostatectomy cohort from EMBARK (NCT02319837). EMBARK enrolled patients who were not eligible for salvage curative treatment or had already received it, he explains, whereas DASL-HiCaP enrolled patients still eligible for cure, who received 24 months of androgen deprivation therapy (ADT) and locoregional radiation therapy with or without darolutamide (Nubeqa). Although event numbers in the salvage setting are small, he reports an HR of about 0.1 in favor of darolutamide and expects it to remain below 0.5 as data mature.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in